Evidence map›Paper›PMID 15229394›Full record

ReviewGlycoconjugate journal2004

The role of defective glycosylation in congenital muscular dystrophy.

Harry Schachter, Jiri Vajsar, Wenli Zhang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Glycoconjugate journal, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Frontiers in genetics · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Glycosylation diseases: quo vadis?Biochimica et biophysica acta · 2009
    Review
  8. Muscle protein alterations in LGMD2I patients with different mutations in the Fukutin-related protein gene.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2008
    Article
  9. Congenital disorders of glycosylation--a challenging group of IEMs.Journal of inherited metabolic disease · 2008
    Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Harry SchachterDepartment of Structural Biology and Biochemistry, The Hospital for Sick Children, 555 University Avenue, Toronto, Ont. M5G 1X8, Canada. harry@sickkids.on.ca
Jiri Vajsar
Wenli Zhang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dystrophin glycoprotein complex (DGC) is an assembly of proteins spanning the sarcolemma of skeletal muscle cells. Defects in the DGC appear to play critical roles in several muscular dystrophies due to disruption of basement membrane organization. O -mannosyl oligosaccharides on alpha-dystroglycan, a major extracellular component of the DGC, are essential for normal binding of alpha-dystroglycan to ligands (such as laminin) in the extracellular matrix and subsequent signal transmission to actin in the cytoskeleton of the muscle cell. Muscle-Eye-Brain disease (MEB) and Walker-Warburg Syndrome (WWS) have mutations in genes encoding glycosyltransferases needed for O -mannosyl oligosaccharide synthesis. Myodystrophic myd mice and humans with Fukuyama Congenital Muscular Dystrophy (FCMD), congenital muscular dystrophy due to defective fukutin-related protein (FKRP) and MDC1D have mutations in putative glycosyltransferases. These human congenital muscular dystrophies and the myd mouse are associated with defective glycosylation of alpha-dystroglycan. It is expected other congenital muscular dystrophies will prove to have mutations in genes involved in glycosylation.

Indexed as

AnimalsDystroglycansDystrophinGlycosylationHumansMuscular DystrophiesProtein BindingDystroglycansDystrophin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.